伊克力西斯 EXEL 深 滬
等待開盤 07-22 09:30:00 美东时间
44.26
-0.210
-0.47%
華盛通- 最 高44.91
- 今 開44.50
- 成交量 179.62万股
- 最 低 44.165
- 昨 收 44.47
- 總市值 120.83亿
- 52周最高 49.62
- 市盈率 靜 25.14
- 換手率 0.66%
- 52周最低 22.96
- 委 比 21.57%
- 總股本 2.73亿
- 歷史最高 49.62
- 量 比 0.96
- 振 幅 1.68%
- 歷史最低 1.26
- 每 手 1
- 風險率 6.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Top rated and bottom rated stocks according to 3 key drivers of performance – UBS
UBS analysts listed top and bottom-ranked stocks based on a key set of drivers for equities, they named REVS. UBS’s REVS framework consists of elements that are key drivers for equity performance, inc...
07-11 23:33
美股大行评级 | 巴克莱上调 Robinhood目标价至102美元；瑞银下调京东目标价从58美元至50美元
今日重点评级关注：摩根大通：维持Cogent Biosciences"超配"评级，目标价从25美元升至29美元；摩根士丹利：维持Legend Biotech"超配"评级，目标价从80美元升至81美元
07-11 09:04
Assessing Exelixis: Insights From 12 Financial Analysts
In the last three months, 12 analysts have published ratings on Exelixis (NASDA...
07-11 05:00
Barclays Maintains Equal-Weight on Exelixis, Raises Price Target to $40
Barclays analyst Peter Lawson maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $29 to $40.
07-11 00:32
Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 8, 2025 /PRNewswire/ -- Equity Insider News Commentary – As cancer rates climb and drug costs c...
07-08 22:25
Peering Into Exelixis's Recent Short Interest
Exelixis's (NYSE:EXEL) short percent of float has risen 9.62% since its last re...
07-05 01:00
美股大行评级 | 巨大分歧！Circle获多家大行首予评级目标价在80~250之间；Stifel上调甲骨文评级至"买入"，目标价升至250美元
美股大行评级 | 巨大分歧！Circle获多家大行首予评级目标价在80~250之间；Stifel上调甲骨文评级至"买入"，目标价升至250美元
07-01 09:24
美股大行评级 | 潜在涨幅390.8%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
多家机构首予Amrize买入评级，目标价53~62美元；HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级>>
06-25 08:39
Stephens & Co. Upgrades Exelixis to Overweight, Raises Price Target to $60
Stephens & Co. analyst Sudan Loganathan upgrades Exelixis (NASDAQ:EXEL) from Equal-Weight to Overweight and raises the price target from $29 to $60.
06-24 21:25
美股大行评级 | 买入！Darden Restaurants获多家大行上调目标价；瑞银维持特斯拉"卖出"评级，目标价升至215美元
买入！Darden Restaurants获多家大行上调目标价；瑞银维持特斯拉"卖出"评级，目标价升至215美元>>
06-24 10:07
